MSD CEO BenShoshan, “I have high expectations on the Korean market”
“The Korean branch is one of the top 10 major branches selected by the MSD’s headquarters. We will put our best effort to much promptly receive the supply of new drugs than other markets.“
On the 19th, Avi BenShoshan, a new CEO of MSD Korea, showed a high expectation on the Korean pharmaceutical...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
